Showing results (141-150 of 270) with videos related to
Sort By:
Pageof 27
BMC Musculoskeletal Disorders|May 1, 2015
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapyGiorgia Martini, Francesca Biscaro, Elisa Boscaro, et al.Therapeutic Advances in Musculoskeletal Disease|October 8, 2020
Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosisNicoletta Del Papa, Gianluca Sambataro, Antonina Minniti, et al.ERJ Open Research|October 13, 2016
Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspectiveIris Bassi, Gill Hollis, Vincent Cottin, et al.Frontiers in Immunology|September 12, 2022
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant periodAndrea Sonaglioni, Michele Lombardo, Adriana Albini, et al.Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|May 2, 2019
Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of ConceptGiuseppe Pelosi, Federica Massa, Gaia Gatti, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 14, 2018
Overall Disability Sum Score for Clinical Assessment of Neurological Involvement in Eosinophilic Granulomatosis With PolyangiitisRoberto Padoan, Maddalena Marconato, Mara Felicetti, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2011
Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in miceFrancesca Lunardi, Gianmarco Villano, Egle Perissinotto, et al.Diabetes Care|April 2, 2010
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alphaGian Paolo Fadini, Elisa Boscaro, Mattia Albiero, et al.Diabetes Care|February 13, 2010
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetesGian Paolo Fadini, Elisa Boscaro, Saula de Kreutzenberg, et al.British Journal of Haematology|March 5, 2003
Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytesRenato Zambello, Livio Trentin, Monica Facco, et al.Pageof 27